Toxicology and antitumour activity of ferrocenylamines and platinum derivatives

Applied Organometallic Chemistry

Volumn 13, Issue 3, 1999, Pages 163-174

  Mason, R W ^a   McGrouther, K ^a   Ranatunge Bandarage, P R R ^a   Robinson, B H ^a   Simpson, J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Antitumour; Ferrocenylamines; Platinum complexes; Toxicity

Indexed keywords

EID: 0001187306     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-0739(199903)13:3<163::aid-aoc821>3.0.co;2-k     Document Type: Article

References (15)

1. K. E. Dombrowski, W. Baldwin and J. E. Sheats, J. Organometal. Chem. 302, 281 (1986).
2. R. P. Hanzlik, P. Soine and W. H. Soine, J. Med. Chem. 22, 424 (1979).
3. R. Kalish, T. V. Steppe and A. Wlaser, J. Med Chem. 18, 222 (1975).
4. J. A. Edwards, R. C. Ursillo and J. E. Hoke, Br. J. Haematol. 28, 445 (1974).
5. J. T. Yarrington, K. W. Huffman, G. A. Leeson, D. J. Syrinkle, D. E. Loudy, C. Hampton, G. J. Wright and J. P. Gipson, Fund. Appl Toxicol. 3, 86 (1983).
6. N. P. Buu-Hoi, Hien-Do-Phouc and C. R. Huynh-Trong-Hieu, C. R. Acad. Sci., Ser. D, 270, 217 (1970).
7. E. I. Edwards, R. Epton and G. Marr, J. Organometal. Chem. 168, 259 (1979).
8. M. Schneider and M. Wenzel, J. Label. Comp. Rad. 18, 293 (1981).
9. R. Tiggemann and M. V. Govidan, Experientia 37, 1066 (1981).
10. I. Haiduc and C. Silvestru, Organometallics in Cancer Chemotherapy, CRC Press, Buca Raton, 1989.
11. P. Köpf-Maier and H. Köpf, Struct. Bonding 70, 103 (1988).
12. P. Köpf-Maier, H. Köpf and E. W. Neuse, J. Cancer Res. Clin. Oncol. 108, 336 (1984).
13. R. A. Yeary, Toxicol. Appl. Pharmacol, 15, 666 (1969).
14. A. R. Dahl and T. J. Briner, Tax. Appl. Pharmacol 56, 232 (1980).
15. R. P. Hanzlik, P. Robert and W. H. Soine, J. Am. Chem. Soc. 180, 1290 (1978).